Instrument Inactif

Autres langues VASOGEN INC. Nasdaq

Actions

CA92232F2026

Cours en clôture Nasdaq
- ^USD	-

Autres langues

19/10/09	VASOGEN INC : Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger
15/10/09	VASOGEN INC : Vasogen Announces Third Quarter 2009 Results
17/08/09	VASOGEN INC : Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company
17/08/09	VASOGEN INC : Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
14/07/09	VASOGEN INC : Vasogen Announces Second Quarter 2009 Results
30/11/-1	VASOGEN : Announces Third Quarter 2008 Results
30/11/-1	VASOGEN : Announces Second Quarter 2008 Results
30/11/-1	VASOGEN : Provides Corporate Update
30/11/-1	Vasogen : Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
30/11/-1	Vasogen : Vasogen Announces Implementation of Strategic Restructuring Plan
30/11/-1	Vasogen : Vasogen Announces First Quarter 2008 Results
30/11/-1	Vasogen : Vasogen to Webcast its Annual Meeting
30/11/-1	Vasogen : Vasogen Provides Update on ACCLAIM II Program
30/11/-1	Vasogen : Vasogen Provides Update on ACCLAIM II Program
30/11/-1	Vasogen : Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
30/11/-1	Vasogen Inc : Rodman & Renshaw, LLC Announces Investment Opinion: Rodman & Renshaw, LLC Initiates Coverage of Vasogen Inc. With A Market Outperform Rating
30/11/-1	VASOGEN : Appoints Dr. Eldon Smith Chairman
30/11/-1	VASOGEN : Announces First Quarter 2009 Results
30/11/-1	VASOGEN : Announces 2008 Year-End Results
30/11/-1	VASOGEN : Announces Sale of Patent Application and Provides Corporate Update
30/11/-1	VASOGEN : Complies with NASDAQ Marketplace Rule 4350(c)(1)
30/11/-1	VASOGEN : Provides Corporate Update